IFM Investors Pty Ltd Acquires 131 Shares of Humana Inc. (NYSE:HUM)

IFM Investors Pty Ltd raised its holdings in Humana Inc. (NYSE:HUM) by 0.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 25,370 shares of the insurance provider’s stock after purchasing an additional 131 shares during the quarter. IFM Investors Pty Ltd’s holdings in Humana were worth $8,036,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of HUM. International Assets Investment Management LLC raised its holdings in shares of Humana by 261,025.1% in the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after buying an additional 738,701 shares during the last quarter. Plan Group Financial LLC acquired a new stake in Humana in the 3rd quarter valued at about $296,000. Lecap Asset Management Ltd. bought a new position in shares of Humana in the third quarter worth about $520,000. Tempus Wealth Planning LLC bought a new position in shares of Humana in the third quarter worth about $253,000. Finally, Eastern Bank acquired a new position in shares of Humana during the third quarter worth approximately $90,000. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on HUM shares. Royal Bank of Canada lowered their price target on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Piper Sandler downgraded Humana from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $392.00 to $274.00 in a research report on Thursday, October 3rd. Bank of America cut Humana from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $376.00 to $247.00 in a report on Wednesday, October 2nd. UBS Group lowered their price objective on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, October 4th. Finally, Oppenheimer cut their target price on shares of Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. One research analyst has rated the stock with a sell rating, nineteen have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $315.33.

Humana Stock Up 0.8 %

Humana stock opened at $260.73 on Friday. The company has a 50 day moving average of $308.31 and a 200-day moving average of $336.88. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $527.18. The stock has a market capitalization of $31.39 billion, a PE ratio of 18.60, a price-to-earnings-growth ratio of 2.04 and a beta of 0.50.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm had revenue of $29.54 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same period in the prior year, the business earned $8.94 EPS. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. On average, equities research analysts anticipate that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.36%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is 25.25%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.